医薬品のグローバル市場展望 2023年-2029年:ブランド医薬品、ジェネリック医薬品

■ 英語タイトル:Pharmaceutical Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23JU5901)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23JU5901
■ 発行日:2023年6月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医薬品&医療
■ ページ数:125
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医薬品のグローバル市場展望 2023年-2029年:ブランド医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の医薬品市場規模と予測を収録しています。・世界の医薬品市場:売上、2018年-2023年、2024年-2029年
・世界の医薬品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医薬品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ブランド医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医薬品のグローバル主要企業は、Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医薬品市場:タイプ別、2018年-2023年、2024年-2029年
世界の医薬品市場:タイプ別市場シェア、2022年
・ブランド医薬品、ジェネリック医薬品

世界の医薬品市場:用途別、2018年-2023年、2024年-2029年
世界の医薬品市場:用途別市場シェア、2022年
・病院、診療所、その他

世界の医薬品市場:地域・国別、2018年-2023年、2024年-2029年
世界の医薬品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医薬品のグローバル売上、2018年-2023年
・主要企業における医薬品のグローバル売上シェア、2022年
・主要企業における医薬品のグローバル販売量、2018年-2023年
・主要企業における医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takeda

*************************************************************

・調査・分析レポートの概要
医薬品市場の定義
市場セグメント
世界の医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医薬品市場規模
世界の医薬品市場規模:2022年 VS 2029年
世界の医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ブランド医薬品、ジェネリック医薬品
医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別医薬品市場規模 2022年と2029年
地域別医薬品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takeda
...

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Drugs. This report contains market size and forecasts of Pharmaceutical Drugs in global, including the following market information:
Global Pharmaceutical Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pharmaceutical Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pharmaceutical Drugs companies in 2022 (%)
The global Pharmaceutical Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pharmaceutical Drugs Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Pharmaceutical Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pharmaceutical Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Pharmaceutical Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pharmaceutical Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharmaceutical Drugs revenues share in global market, 2022 (%)
Key companies Pharmaceutical Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pharmaceutical Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Drugs, market overview.
Chapter 2: Global Pharmaceutical Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical Drugs Overall Market Size
2.1 Global Pharmaceutical Drugs Market Size: 2022 VS 2029
2.2 Global Pharmaceutical Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pharmaceutical Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Pharmaceutical Drugs Players in Global Market
3.2 Top Global Pharmaceutical Drugs Companies Ranked by Revenue
3.3 Global Pharmaceutical Drugs Revenue by Companies
3.4 Global Pharmaceutical Drugs Sales by Companies
3.5 Global Pharmaceutical Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pharmaceutical Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pharmaceutical Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharmaceutical Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pharmaceutical Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharmaceutical Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharmaceutical Drugs Market Size Markets, 2022 & 2029
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type – Global Pharmaceutical Drugs Revenue & Forecasts
4.2.1 By Type – Global Pharmaceutical Drugs Revenue, 2018-2023
4.2.2 By Type – Global Pharmaceutical Drugs Revenue, 2024-2029
4.2.3 By Type – Global Pharmaceutical Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Pharmaceutical Drugs Sales & Forecasts
4.3.1 By Type – Global Pharmaceutical Drugs Sales, 2018-2023
4.3.2 By Type – Global Pharmaceutical Drugs Sales, 2024-2029
4.3.3 By Type – Global Pharmaceutical Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Pharmaceutical Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmaceutical Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Pharmaceutical Drugs Revenue & Forecasts
5.2.1 By Application – Global Pharmaceutical Drugs Revenue, 2018-2023
5.2.2 By Application – Global Pharmaceutical Drugs Revenue, 2024-2029
5.2.3 By Application – Global Pharmaceutical Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Pharmaceutical Drugs Sales & Forecasts
5.3.1 By Application – Global Pharmaceutical Drugs Sales, 2018-2023
5.3.2 By Application – Global Pharmaceutical Drugs Sales, 2024-2029
5.3.3 By Application – Global Pharmaceutical Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Pharmaceutical Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pharmaceutical Drugs Market Size, 2022 & 2029
6.2 By Region – Global Pharmaceutical Drugs Revenue & Forecasts
6.2.1 By Region – Global Pharmaceutical Drugs Revenue, 2018-2023
6.2.2 By Region – Global Pharmaceutical Drugs Revenue, 2024-2029
6.2.3 By Region – Global Pharmaceutical Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Pharmaceutical Drugs Sales & Forecasts
6.3.1 By Region – Global Pharmaceutical Drugs Sales, 2018-2023
6.3.2 By Region – Global Pharmaceutical Drugs Sales, 2024-2029
6.3.3 By Region – Global Pharmaceutical Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pharmaceutical Drugs Revenue, 2018-2029
6.4.2 By Country – North America Pharmaceutical Drugs Sales, 2018-2029
6.4.3 US Pharmaceutical Drugs Market Size, 2018-2029
6.4.4 Canada Pharmaceutical Drugs Market Size, 2018-2029
6.4.5 Mexico Pharmaceutical Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pharmaceutical Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Pharmaceutical Drugs Sales, 2018-2029
6.5.3 Germany Pharmaceutical Drugs Market Size, 2018-2029
6.5.4 France Pharmaceutical Drugs Market Size, 2018-2029
6.5.5 U.K. Pharmaceutical Drugs Market Size, 2018-2029
6.5.6 Italy Pharmaceutical Drugs Market Size, 2018-2029
6.5.7 Russia Pharmaceutical Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Pharmaceutical Drugs Market Size, 2018-2029
6.5.9 Benelux Pharmaceutical Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pharmaceutical Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Pharmaceutical Drugs Sales, 2018-2029
6.6.3 China Pharmaceutical Drugs Market Size, 2018-2029
6.6.4 Japan Pharmaceutical Drugs Market Size, 2018-2029
6.6.5 South Korea Pharmaceutical Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Pharmaceutical Drugs Market Size, 2018-2029
6.6.7 India Pharmaceutical Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pharmaceutical Drugs Revenue, 2018-2029
6.7.2 By Country – South America Pharmaceutical Drugs Sales, 2018-2029
6.7.3 Brazil Pharmaceutical Drugs Market Size, 2018-2029
6.7.4 Argentina Pharmaceutical Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pharmaceutical Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pharmaceutical Drugs Sales, 2018-2029
6.8.3 Turkey Pharmaceutical Drugs Market Size, 2018-2029
6.8.4 Israel Pharmaceutical Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Pharmaceutical Drugs Market Size, 2018-2029
6.8.6 UAE Pharmaceutical Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pharmaceutical Drugs Major Product Offerings
7.1.4 Pfizer Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Pharmaceutical Drugs Major Product Offerings
7.2.4 Roche Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Pharmaceutical Drugs Major Product Offerings
7.3.4 Sanofi Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Pharmaceutical Drugs Major Product Offerings
7.4.4 Johnson & Johnson Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Pharmaceutical Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co. (MSD) Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Pharmaceutical Drugs Major Product Offerings
7.6.4 Novartis Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Pharmaceutical Drugs Major Product Offerings
7.7.4 AbbVie Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Pharmaceutical Drugs Major Product Offerings
7.8.4 Gilead Sciences Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Pharmaceutical Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Pharmaceutical Drugs Major Product Offerings
7.10.4 Amgen Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Pharmaceutical Drugs Business Overview
7.11.3 AstraZeneca Pharmaceutical Drugs Major Product Offerings
7.11.4 AstraZeneca Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Pharmaceutical Drugs Business Overview
7.12.3 Bristol-Myers Squibb Pharmaceutical Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Pharmaceutical Drugs Business Overview
7.13.3 Eli Lilly Pharmaceutical Drugs Major Product Offerings
7.13.4 Eli Lilly Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Pharmaceutical Drugs Major Product Offerings
7.14.4 Teva Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Teva Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Pharmaceutical Drugs Major Product Offerings
7.15.4 Bayer Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Bayer Key News & Latest Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Pharmaceutical Drugs Major Product Offerings
7.16.4 Novo Nordisk Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Novo Nordisk Key News & Latest Developments
7.17 Allergan
7.17.1 Allergan Company Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Pharmaceutical Drugs Major Product Offerings
7.17.4 Allergan Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Allergan Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Pharmaceutical Drugs Major Product Offerings
7.18.4 Takeda Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Pharmaceutical Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
7.20 Takeda
7.20.1 Takeda Company Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Pharmaceutical Drugs Major Product Offerings
7.20.4 Takeda Pharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Key News & Latest Developments
8 Global Pharmaceutical Drugs Production Capacity, Analysis
8.1 Global Pharmaceutical Drugs Production Capacity, 2018-2029
8.2 Pharmaceutical Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharmaceutical Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharmaceutical Drugs Supply Chain Analysis
10.1 Pharmaceutical Drugs Industry Value Chain
10.2 Pharmaceutical Drugs Upstream Market
10.3 Pharmaceutical Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharmaceutical Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23JU5901 )"医薬品のグローバル市場展望 2023年-2029年:ブランド医薬品、ジェネリック医薬品" (英文:Pharmaceutical Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。